Cardlytics, Inc. announced consolidated impairment charge for the second quarter ended June 30, 2022. For the quarter, the company reported Goodwill impairment of $83,149,000.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.49 USD | -1.02% | -4.73% | +57.33% |
Mar. 26 | Sector Update: Tech Stocks Mixed Late Afternoon | MT |
Mar. 26 | Top Midday Decliners | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+57.33% | 703M | |
-20.24% | 1.77B | |
-13.25% | 590M | |
+16.59% | 412M | |
-23.72% | 393M | |
-13.08% | 203M | |
+20.10% | 174M | |
+20.56% | 123M | |
+7.74% | 99.2M | |
-20.00% | 92.97M |
- Stock
- Equities
- Stock Cardlytics, Inc. - Nasdaq
- News Cardlytics, Inc.
- Cardlytics, Inc. Announces Consolidated Impairment Charge for the Second Quarter Ended June 30, 2022